
Dr Davide Danovi
Senior Lecturer
Research interests
- Biomedical and life sciences
Biography
Davide’s group at the Centre for Stem Cells and Regenerative Medicine launched within the framework of the Human Induced Pluripotent Stem Cells Initiative (HipSci) project, funded by Wellcome and MRC. Within this framework, his team have implemented methods to characterise cell behaviour of human iPS cells based on microscopy images collating data with genomics. This work has formed the basis for an innovative collaborative cell phenotyping space - The Stem Cell Hotel.
Davide was awarded the FLIER (Future Leader for Innovation Enterprise and Research) from the Academy of Medical Sciences. In parallel to his role at King's, he has recently joined an award winning Cambridge biotech.
He has several years of experience in high content analysis (both in live and end-point conditions) to characterise stem cell behaviour in academia and industry. He holds an MD from University of Milan and a PhD in Molecular Oncology from the European Institute of Oncology where he demonstrated the causative role of the HdmX protein in human cancer and completed his postdoctoral training with Austin Smith and Steve Pollard at University of Cambridge and University College London where he has developed screening platforms to isolate compounds active on human neural stem cells from brain tumour samples.
Research

Cell Phenotyping Group
The group launched within the framework of the Human Induced Pluripotent Stem Cells Initiative (HipSci) project, funded by Wellcome and MRC.
News
New tool identifies which cells will best repair muscles
Collaborators at King’s and UCL have published their findings on the tool which uses images to indicate the best cells to be implanted to repair damaged and...

Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.

First-ever shipping container labs for COVID-19 testing
Researchers from King's have joined a multidisciplinary team led by OpenCell.bio that has developed a low-cost, rapidly deployable COVID-19 testing lab inside...

Features
Exploring the Commercial Potential of Research: Migration Biotherapeutics
Read how the Migration Biotherapeutics team are accelerating their research through innovation and impact.

Research

Cell Phenotyping Group
The group launched within the framework of the Human Induced Pluripotent Stem Cells Initiative (HipSci) project, funded by Wellcome and MRC.
News
New tool identifies which cells will best repair muscles
Collaborators at King’s and UCL have published their findings on the tool which uses images to indicate the best cells to be implanted to repair damaged and...

Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.

First-ever shipping container labs for COVID-19 testing
Researchers from King's have joined a multidisciplinary team led by OpenCell.bio that has developed a low-cost, rapidly deployable COVID-19 testing lab inside...

Features
Exploring the Commercial Potential of Research: Migration Biotherapeutics
Read how the Migration Biotherapeutics team are accelerating their research through innovation and impact.
